Antioxidant enzymes in red blood cells and lymphocytes of ataxia-telangiectasia patients

Turkish Journal of Pediatrics

Volumn 46, Issue 3, 2004, Pages 204-207

  Aksoy, Yasemin ^a   Sanal, Özden ^a   Metin, Ayşe ^b   Tezcan, Ilhan ^a   Ersoy, Fügen ^a   Öǧüş, Hamdi ^a   Özer, Nazmi ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Social Security Hospital   (Turkey)

Author keywords

Antioxidant enzymes; Ataxia telangiectasia; Erythrocyte; Lymphocyte

Indexed keywords

ANTIOXIDANT; ATM PROTEIN; CATALASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; OXYGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ADOLESCENT; ADULT; ARTICLE; ATAXIA TELANGIECTASIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; OXIDATIVE STRESS; PHENOTYPE; PLEIOTROPY; SCHOOL CHILD;

ADOLESCENT; ATAXIA TELANGIECTASIA; CATALASE; CHILD; ERYTHROCYTES; FEMALE; HUMANS; LYMPHOCYTES; MALE; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 4644285152     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Halliwell B, Gutteridge JMC, Cross CE. Free radicals, antioxidants and human disease: where are we now? Lab Clin Med 1992; 119: 598-620.
2. Cerutti P. Oxy-radicals and cancer. Lancet 1994; 344: 862-863.
3. Cerutti P. Prooxidant states and tumor promotion. Science 1985; 227: 375-380.
4. Lavin MF, Shiloh Y. The genetic defect in ataxia-telangiectasia. Annu Rev Immunol 1997; 15: 177-202.
5. Lavin MF, Shiloh Y. Ataxia-telangiectasia: a multifaceted genetic disorder associated with defective signal transduction. Curr Opin Immunol 1996; 8: 459-464.
6. Rothman G, Shiloh Y. Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress? Bioessays 1997; 19: 911-917.
7. Beutler E. Red Cell Metabolism. New York and London: Grune Stratton; 1971.
8. Mannervik B, Guthenberg C. Glutathione transferase (human placenta). Methods Enzymol 1981; 77: 231-235.
9. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-127.
10. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
11. Lowry ON, Rosebrough NJ, For L, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-270.
12. Vuillaume M. Reduced oxygen species, mutation induction and cancer initiation. Mutat Res 1987; 186: 43-72.
13. Meredith MJ, Dodson JL. Impaired gluttahione biosynthesis in cultured human ataxia-telangiectasia cells. Cancer Res 1987; 47: 4576-4581.
14. Dean SW. Some aspects of glutathione metabolism in ataxia-telangiectasia fibroblasts. Int J Radiat Biol Relat Stud Phys Chem Med 1987; 52: 43-48.
15. Dean SW, Jaspers NG. Letter to the editor. Cancer Res 1988; 48: 5374-5376.
16. Sheridan RB, III Huang PC. Superoxide dismutase and catalase activities in ataxia-telangiectasia and normal fibroblast cell extracts. Mutat Res 1979; 61: 381-386.
17. Shiloh Y, Tabor E, Becker Y. Abnormal response of ataxia-telangiectasia cells to agents that break the deoxyribose moiety of DNA via targeted free radical mehanism. Carcinogenesis 1983; 4: 1317-1322.
18. Reichenbach J, Schubert R, Schwan C, Müller K, Böhles HJ, Zielen S. Anti-oxidative capacity in patients with ataxia telangiectasia. Clin Exp Immunol 1999; 117: 535-539.
19. Cao G, Prior RL. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem 1998; 44: 1309-1315.